Company / Gross Margin
Beta Bionics, Inc. Gross Margin History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
55.4%
FY2025
5-year range
52.6% / 55.4%
FY2023-FY2025
Trend
+0.5%
vs FY2024
Sector context
#52 of 96
Health Care
What the data says
At 55.4%, Beta Bionics, Inc.'s gross margin ranks #52 of 96 in the Health Care sector. Gross Margin remained relatively stable over the past 3 years, with values between 52.6% and 55.4%.
Based on SEC 10-K filings.
55.4% in FY2025.
Improved from 52.6% to 55.4% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#52 of 96 in Health CareTop 54% of 96This company 55.4% Sector average 53.6%
▼
+3.4% above sector average
Key checks
Key Insights
- In FY2025, gross margin increased 0.5% year-over-year.
- Currently 1.8pp above the Health Care sector average.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 55.4% | +0.5% |
| FY2024 | 55.1% | +4.8% |
| FY2023 | 52.6% | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026